🇺🇸 FDA
Patent

US 10532056

Therapeutic compositions, combinations, and methods of use

granted A61KA61K31/337A61K31/506

Quick answer

US patent 10532056 (Therapeutic compositions, combinations, and methods of use) held by VERASTEM, INC. expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VERASTEM, INC.
Grant date
Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/337, A61K31/506, A61K31/5377, A61K31/7068